Direct protein–protein interaction between the intracellular domain of TRA-2 and the transcription factor TRA-1A modulates feminizing activity in C. elegans

  1. David H. Lum1,
  2. Patricia E. Kuwabara2,
  3. David Zarkower3, and
  4. Andrew M. Spence1,4
  1. 1Department of Molecular and Medical Genetics, University of Toronto, Toronto, M5S 1A8, Canada; 2The Sanger Centre, Wellcome Trust Genome Campus, Hinxton, Cambridge, CB10 1SA, UK; 3Department of Genetics, Cell Biology and Development, University of Minnesota, Minneapolis, Minnesota 55455, USA

Abstract

In the nematode Caenorhabditis elegans, the zinc finger transcriptional regulator TRA-1A directs XX somatic cells to adopt female fates. The membrane protein TRA-2A indirectly activates TRA-1A by binding and inhibiting a masculinizing protein, FEM-3. Here we report that a part of the intracellular domain of TRA-2A, distinct from the FEM-3 binding region, directly binds TRA-1A. Overproduction of this TRA-1A-binding region has tra-1-dependent feminizing activity in somatic tissues, indicating that the interaction enhances TRA-1A activity. Consistent with this hypothesis, we show thattra-2(mx) mutations, which weakly masculinize somatic tissues, disrupt the TRA-2/TRA-1A interaction. Paradoxically,tra-2(mx) mutations feminize the XX germ line, as do tra-1 mutations mapping to the TRA-2 binding domain. We propose that these mutations render tra-2 insensitive to a negative regulator in the XX germ line, and we speculate that this regulator targets the TRA-2/TRA-1 complex. The intracellular domain of TRA-2A is likely to be produced as a soluble protein in vivo through proteolytic cleavage of TRA-2A or through translation of anXX germ line-specific mRNA. We further show that tagged derivatives of the intracellular domain of TRA-2 localize to the nucleus, supporting the hypothesis that this domain is capable of modulating TRA-1A activity in a manner reminiscent of Notch and Su(H).

Keywords

Footnotes

  • 4 Corresponding author.

  • E-MAIL andrew.spence{at}utoronto.ca; FAX (416) 978-6885.

  • Article and publication are at www.genesdev.org/cgi/doi/10.1101/gad.853700.

    • Received September 25, 2000.
    • Accepted November 3, 2000.
| Table of Contents

Life Science Alliance